OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Therapeutics for Epstein–Barr Virus
Graciela Andreï, Erika Trompet, Robert Snoeck
Molecules (2019) Vol. 24, Iss. 5, pp. 997-997
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Epstein–Barr Virus History and Pathogenesis
Yu Hui, Erle S. Robertson
Viruses (2023) Vol. 15, Iss. 3, pp. 714-714
Open Access | Times Cited: 55

Stress-Induced Epstein-Barr Virus Reactivation
Daniel Sausen, Maimoona Bhutta, Elisa Gallo, et al.
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1380-1380
Open Access | Times Cited: 70

Anti-viral triterpenes: a review
Priya Darshani, Shreya Sen Sarma, Amit Kumar Srivastava, et al.
Phytochemistry Reviews (2022) Vol. 21, Iss. 6, pp. 1761-1842
Open Access | Times Cited: 54

Epstein-Barr virus infection: the micro and macro worlds
Wei Huang, Lang Bai, Hong Tang
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 28

MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets
Muneyoshi Kimura, Sagar Kothari, Wajiha Gohir, et al.
Clinical Microbiology Reviews (2023) Vol. 36, Iss. 4
Closed Access | Times Cited: 26

Infectious Mononucleosis: An Updated Review
Alexander K. C. Leung, Joseph M. Lam, Benjamin Barankin
Current Pediatric Reviews (2023) Vol. 20, Iss. 3, pp. 305-322
Closed Access | Times Cited: 25

Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma
Qian‐Ying Zhu, Gexin Zhao, Yan Li, et al.
MedComm (2021) Vol. 2, Iss. 2, pp. 175-206
Open Access | Times Cited: 41

Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf
Erik De Clercq, Yike Jiang, Guangdi Li
Travel Medicine and Infectious Disease (2022) Vol. 52, pp. 102528-102528
Open Access | Times Cited: 33

The Fight against the Carcinogenic Epstein-Barr Virus: Gut Microbiota, Natural Medicines, and Beyond
Radwa A. Eladwy, Hang Thi Vu, Ravi Shah, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1716-1716
Open Access | Times Cited: 20

Treatment of Epstein-Barr Virus infection in immunocompromised patients
Martyna Pociupany, Robert Snoeck, Daan Dierickx, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116270-116270
Closed Access | Times Cited: 8

The Function and Therapeutic Potential of Epstein-Barr Virus-Encoded MicroRNAs in Cancer
Man Wang, Bianli Gu, Xinzhe Chen, et al.
Molecular Therapy — Nucleic Acids (2019) Vol. 17, pp. 657-668
Open Access | Times Cited: 44

Identification of Potential Inhibitors against Epstein–Barr Virus Nuclear Antigen 1 (EBNA1): An Insight from Docking and Molecular Dynamic Simulations
Shweta Jakhmola, Nisha Amarnath Jonniya, Md Fulbabu Sk, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 16, pp. 3060-3072
Closed Access | Times Cited: 38

Drug Discovery of Nucleos(t)ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday
Guangdi Li, Tingting Yue, Pan Zhang, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 923-923
Open Access | Times Cited: 34

Viral miRNAs as Active Players and Participants in Tumorigenesis
Alessia Gallo, Vitale Miceli, Matteo Bulati, et al.
Cancers (2020) Vol. 12, Iss. 2, pp. 358-358
Open Access | Times Cited: 35

EBV+ lymphoproliferative diseases: opportunities for leveraging EBV as a therapeutic target
Keri Toner, Catherine M. Bollard
Blood (2021) Vol. 139, Iss. 7, pp. 983-994
Open Access | Times Cited: 28

Deciphering antiviral efficacy of malaria box compounds against malaria exacerbating viral pathogens- Epstein Barr virus and SARS-CoV-2, an in silico study
Omkar Indari, Ajit Kumar Singh, Deeksha Tiwari, et al.
Medicine in Drug Discovery (2022) Vol. 16, pp. 100146-100146
Open Access | Times Cited: 21

Human Gammaherpesvirus 8 Oncogenes Associated with Kaposi’s Sarcoma
Amanda de Oliveira Lopes, Pedro do Nascimento Marinho, Letícia d’Ambrosio de Souza Medeiros, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7203-7203
Open Access | Times Cited: 19

Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities
Shivam Chowdhary, Rahul Deka, Kingshuk Panda, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 8, pp. 3698-3740
Open Access | Times Cited: 12

The innate and T-cell mediated immune response during acute and chronic gammaherpesvirus infection
Viktoria Rex, Razieh Zargari, Markus Stempel, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 11

In silico elucidation for the identification of potential phytochemical against ACE-II inhibitors
Ekambaram Gayathiri, Palanisamy Prakash, Kuppusamy Selvam, et al.
Journal of Molecular Modeling (2024) Vol. 30, Iss. 3
Closed Access | Times Cited: 4

Precision Meets Repurposing: Innovative Approaches in Human Papillomavirus and Epstein-Barr Virus-Driven Cancer Therapy
Queenie Fernandes
Cancer Letters (2024) Vol. 607, pp. 217318-217318
Closed Access | Times Cited: 4

Emerging drugs for Epstein-Barr virus associated-diseases
Nassima Oumata, Qian Zhong, Yongmin Zhang, et al.
European Journal of Medicinal Chemistry (2025), pp. 117386-117386
Closed Access

Epstein‐Barr Virus‐Associated Pneumonia in a Healthy Adult Presenting With Pulmonary Nodules and Deep Vein Thrombosis: A Case Report and Literature Review
Payam Tabarsi, Marjan Hemmatian, Maryam Moradi
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access

Page 1 - Next Page

Scroll to top